Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2967965 | 0.77 | GSTP1 (0.39) | ALDH1A1CYP1A2MAPTCYP2C19 | |
| SCHEMBL4460819 | 0.68 | — | — | |
| SCHEMBL2264535 | 0.68 | CYP1A2 (0.36) | ALDH1A1CYP1A2 | |
| SCHEMBL6238908 | 0.66 | ALDH1A1 (0.44) | ALDH1A1TDO2CYP1A2CYP2D6MAPT | |
| SCHEMBL27674356 | 0.65 | CYP2A6 (0.38) | ALDH1A1MAPT | |
| SCHEMBL14190040 | 0.64 | ALDH1A1 (0.42) | ALDH1A1TDO2CYP1A2CYP2D6MAPT | |
| SCHEMBL4467536 | 0.64 | ALDH1A1 (0.39) | ALDH1A1CYP1A2MAPTCYP2C19 | |
| SCHEMBL7435648 | 0.64 | TP53 (0.31) | ALDH1A1MAPT | |
| Triphenylene SCHEMBL29177860 | 0.60 | ALDH1A1 (0.75) | ALDH1A1CYP1A2 | |
| Triphenylene SCHEMBL29177868 | 0.60 | ALDH1A1 (0.75) | ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100025661-A1 | Luminescent material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2010-02-04 | — | — | US | claimed |
| US-20100025661-A1 | Luminescent material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100025661-A1 | Luminescent material and organic electroluminescent device using the same | TRPV3, TRPC3, HVCN1 | ALDH1A1 944/4885TDO2 257/4885CYP1A2 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.